Table 2 Patients’ pre-operative diagnosis, MRI staging, post-operative histological type, histological stage and histological grade of endometrial carcinoma
TAH (n = 49) | TLH (n = 32) | p value | ||
|---|---|---|---|---|
Pre-operative diagnosis [n (%)] | Endometrial carcinoma | 42 (85.7) | 20 (62.5) | 0.038* |
Atypical hyperplasia | 3 (6.1) | 8 (25.0) | ||
Complex hyperplasia | 1 (2.0) | 1 (3.1) | ||
Other | 2 (4.1) | 2 (6.3) | ||
MRI Stage [n (%)] | IA | 5 (10.2) | 9 (28.1) | 0.076 |
IB | 10 (20.4) | 6 (18.8) | ||
IC | 7 (14.3) | 0 | ||
IIA | 2 (4.1) | 0 | ||
IIB | 2 (4.1) | 1 (3.1) | ||
IIIA | 2 (4.1) | 0 | ||
IIIB | 0 | 0 | ||
IIIC | 3 (6.1) | 0 | ||
IV | 1 (2.0) | 0 | ||
Primary tumour not identified | 2 (4.1) | 4 (12.5) | ||
No MRI | 15 (30.6) | 12 (37.5) | ||
Post-operative histological type [n (%)] | Endometroid Adenocarcinoma | 40 (81.6) | 27 (84.4) | 0.018* |
Carcinosarcoma | 6 (12.2) | 0 | ||
Serous papillary carcinoma | 2 (4.1) | 0 | ||
Benign disease | 1 (2.0) | 5 (15.5) | ||
Post-operative histological stage [n (%)] | IA | 4 (8.2) | 10 (31.3) | 0.011* |
IB | 21 (42.9) | 12 (37.5) | ||
IC | 8 (16.3) | 1 (3.1) | ||
IIA | 1 (2.0) | 0 | ||
IIB | 5 (10.2) | 1 (3.1) | ||
IIIA | 7 (14.3) | 3 (9.4) | ||
IIIB | 0 | 1 (3.1) | ||
IIIC | 2 (4.1) | 0 | ||
IV | 1 (2.0) | 0 | ||
No histological stage reported | 0 | 4 (12.5) | ||
Post-operative histological grade [n (%)] | I | 16 (32.7) | 15 (46.9) | 0.187 |
II | 23 (46.9) | 9 (28.1) | ||
III | 8 (16.3) | 4 (12.5) | ||
No histological grade reported | 2 (4.1) | 4 (12.5) | ||